The Freedom 100 Emerging Markets ETF (FRDM) was downgraded from Strong Buy to Buy following an approximately 85% rally driven by heavy exposure to Korean memory and Taiwanese AI hardware stocks. This shift has made FRDM's portfolio highly concentrated in these sectors, which now make up nearly half of its holdings, reducing its appeal as a diversified emerging market investment. While valuation caution is advised, strong memory fundamentals are expected to support the ETF through mid-2027. Investors should now view FRDM more as a play on ex-US semiconductors and AI infrastructure rather than a traditional emerging market ETF, emphasizing careful position sizing and monitoring of the memory cycle.
The Freedom 100 Emerging Markets ETF (FRDM) is the subject, with Pluang's Technology sector data providing context. As of Sep 29, 2026 03:03 WIB, 36 of 150 priced US Technology stocks rose while 113 fell. Notable movers include APLD at USD 24.57 with a -6.40% change and 100% buy order activity, FSLY at USD 24.98 with a -6.37% change and 91% buy order activity, and WIX at USD 69.28 with a -6.11% change and 100% sell order activity.
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...
A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...
Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...
